No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortality.

par Lise Lotte N Husemoen, Tea Skaaby, Torben Jørgensen, Jacob P Thyssen, Michael Meldgaard, Pal B Szecsi, Steen Stender, Jeanne Duus Johansen, Allan Linneberg
Publié 2013